Navigation Links
PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
Date:11/15/2010

PRINCETON, N.J., Nov. 15, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, announced today that it is launching a new brand identity and tagline, "PharmaNet Works For You".  The new brand and tagline reflect the Company's promise to its clients to provide intelligent solutions to accelerate drug development programs consistent with the highest standards of regulatory compliance, quality and reliability.

The new branding unifies PharmaNet's messaging across all of its subsidiaries and services, and clearly articulates the entire Company's commitment to client service around the world. PharmaNet has the global reach and experience to execute clinical development programs from small local projects to large global programs with a custom-fit philosophy that provides a personalized approach to client service.

PharmaNet's new brand identity has already appeared in a pre-launch advertising campaign running in digital and print industry publications. It will be formally launched at two upcoming industry events, the 2010 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in New Orleans, Louisiana, from November 14-18 and the 9th Annual Partnerships in Clinical Trials Conference in Vienna, Austria, from November 16-19.  

"The trusted PharmaNet name now serves as the umbrella brand for all our global clinical development service offerings, from bioequivalence and bioanalytical services to Phase I – IV programs," said Jeffrey P. McMullen, Chief Executive Officer, PharmaNet.

"We have taken on this initiative to strengthen and modernize our brand into one voice," Mr. McMullen explained. "This investment in PharmaNet's future demonstrates commitment to our clients and provides a solid foundation for our continued expansion of services, geographies, and capabilities."  

About PharmaNet Development Group, Inc.PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet Works For You. For more information, please visit www.PharmaNet.com.Contact: Anne-Marie HessPhone:   (609) 951-6842E-mail:   ahess@pharmanet.com
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaNet Development Group Announces Observational Research Survey
2. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
3. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
6. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
7. PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
8. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
9. World-Renowned Singer Youssou NDour Launches NightWatch Program
10. CRi Launches the TRIO™ Multispectral Imaging System for Multi-Analyte Investigation in Tissue
11. IntegenX Launches the Apollo 324 System for Automated DNA Library Preparation at the ASHG Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):